✦ LIBER ✦

Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer

✍ Scribed by Glenn Liu; Kurt Oettel; Howard Bailey; Lynn Van Ummersen; Kendra Tutsch; Mary Jane Staab; Dorothea Horvath; Dona Alberti; Rhoda Arzoomanian; Hamied Rezazadeh; James McGovern; Emily Robinson; David DeMets; George Wilding

Book ID: 111550629
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 63 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1025437115182

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of daily oral perillyl al

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer

✍ Howard H. Bailey; Steven Attia; Richard R. Love; Terri Fass; Rick Chappell; Kend 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 340 KB

Phase II Trial of Perillyl Alcohol in Pa

Phase II Trial of Perillyl Alcohol in Patients with Metastatic Colorectal Cancer

✍ Meadows, Sherry Morgan ;Mulkerin, Daniel ;Berlin, Jordan ;Bailey, Howard ;Kolesa 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 59 KB

Phase II trial of GM-CSF + thalidomide i

Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer

✍ Robert Dreicer; Eric A. Klein; Paul Elson; David Peereboom; Tatiana Byzova; Edwa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A Phase II trial of green tea in the tre

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

✍ Aminah Jatoi; Neil Ellison; Patrick A. Burch; Jeff A. Sloan; Shaker R. Dakhil; P 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: Recent laboratory and epidemiologic studies have suggested that green tea has antitumor effects in patients with prostate carcinoma. this phase ii trial explored green tea's antineoplastic effects in patients with androgen independent prostate carcinoma. ## Methods: This study, whi

Phase I/II Trial of Bortezomib plus Doce

Phase I/II Trial of Bortezomib plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer

✍ Price, Nancy; Dreicer, Robert; Hutson, Tom; Jain, Vinay K.; Sartor, Oliver 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

A Phase II Trial of Daily Perillyl Alcoh

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

✍ Howard H. Bailey; Donna Levy; Linda S. Harris; Julian C. Schink; Francine Foss; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB